Decoding Cellular Signals: Advancing Therapeutics Through GPCR Science - Prof. Paul A. Insel
By: Gayatri Srinivas
Conference Manager, InnoPharm 2026
11/17/2025
Prof. Paul A. Insel to Deliver Plenary Session (In-Person) at InnoPharm-2026.
InnoPharm-2026 is delighted to welcome Prof. Paul A. Insel, Distinguished Professor at the University of California, San Diego, as a Plenary Speaker.
Prof. Insel is internationally recognized for his groundbreaking contributions to pharmacology, particularly in the field of G protein-coupled receptors (GPCRs), which represent one of the largest and most important classes of drug targets. His research has significantly advanced the understanding of how cells communicate, respond to external stimuli, and regulate complex biological processes.
Throughout his career, Prof. Insel has contributed to elucidating the molecular mechanisms underlying receptor signaling and drug action. His work has influenced both fundamental science and clinical pharmacology, shaping how therapies are developed for a wide range of conditions including cardiovascular, metabolic, and neurological disorders.
Why It Matters:
GPCRs are central to modern drug discovery, with a substantial proportion of approved drugs targeting these receptors. Prof. Insel’s research provides critical insights into improving drug specificity, minimizing side effects, and enhancing therapeutic efficacy. His contributions continue to guide the development of next-generation therapeutics that are more precise and effective.
About Prof. Insel:
- Distinguished Professor, University of California, San Diego
- Leading authority in GPCR biology and signaling pathways
- Extensive contributions to pharmacology and drug discovery
- Mentor and collaborator to scientists across academia and industry